Skip to main content
. 2019 Feb;22(2):154–159. doi: 10.22038/ijbms.2018.31225.7534

Figure 4.

Figure 4

The level of caspase 3 in the hippocampus of the studied groups. A: sham (SH) group, B: chronic cerebral hypoperfusion (CCH) group, C: CCH +berberine (BBR) 50 group, D: CCH+BBR 100 group. The black arrows indicate the expression of the caspase 3 (magnification ×400)